Loading stock data…
NGVT
$71.26-0.30 (-0.42%)
Market ClosedLast close May 13
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ingevity Corporation in the Basic Materials sector is trading at $71.26. Wall Street consensus targets $85.50 (4 analysts), implying a +20.0% move over the next 12 months. The stock is currently 10% below its 52-week high of $79.29, remaining 15.6% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$71.26
Potential Downside
0%
Whystock Fair Value$71.26
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Buy
Mean target$85.50+20.0%
Range$75.00 – $92.00
Fundamentals
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments:...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.63B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.27
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-729.29%
Volume
Today's trading volume
160,616
Recent News
Ingevity Q1 Earnings Call Highlights
Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases. On the company’s earnings call, President and CEO
NGVT Q1 Earnings Top Estimates on Pricing and FX Tailwinds
Ingevity beats Q1 estimates as pricing actions and FX gains lift sales and earnings, despite weakness in Road Markings and lower asset utilization.
The Bull Case For Ingevity (NGVT) Could Change Following Q1 2026 Results And Portfolio Reshaping Steps
In the past week, Ingevity Corporation reported first-quarter 2026 results with sales of US$258.0 million and net income of US$59.8 million, while advancing portfolio reshaping through divestitures and reaffirming full-year guidance. At the same time, shareholders expanded the 2025 Omnibus Incentive Plan by 580,000 shares and approved ESOP-related shelf registration, highlighting an emphasis on equity-based compensation and employee ownership alongside a tighter focus on higher-margin...
Ingevity Corporation Q1 2026 Earnings Call Summary
Moby summary of Ingevity Corporation's Q1 2026 earnings call
Ingevity (NGVT) Beats Q1 Earnings and Revenue Estimates
Ingevity (NGVT) delivered earnings and revenue surprises of +36.91% and +3.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?